Knobbe Martens client, C.R. Bard has acquired Medivance Inc. for $250 million and will become part of the Bard Medical division. C.R. Bard provides medical technologies in the fields of vascular, urology, oncology and surgical specialty products.
Medivance is a leader in the growing field of therapeutic hypothermia and makes the Arctic Sun line of products. These products allow physicians to effectively control body core temperature, in a treatment known as therapeutic hypothermia, during the treatment of critically ill patients. Medivance’s technology provides an innovative, non-invasive way to rapidly transfer heat from a patient so as to effectively manage body core temperature.
Knobbe Martens partners Bill Shreve and James Herkenhoff, and associates Madhavi Patankar and David Kujawa analyzed and evaluated Medivance’s patent portfolio as well as hundreds of third party patents.
With over 275 lawyers and scientists nationwide, Knobbe Martens Olson & Bear LLP dedicates its practice to all aspects of intellectual property law including litigation. Consistently ranked among the top intellectual property firms worldwide, Knobbe Martens serves a diverse group of clients from multinational corporations to emerging businesses of all stages. Headquartered in Orange County, California, Knobbe Martens also has offices in San Diego, Los Angeles, Riverside, San Francisco, Silicon Valley, Seattle and Washington, D.C. More information about the firm can be found at www.knobbe.com
